These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 19558260)
1. Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: case report and review of the literature. Christiansen SR; Broniscer A; Panetta JC; Stewart CF Pharmacotherapy; 2009 Jul; 29(7):858-66. PubMed ID: 19558260 [TBL] [Abstract][Full Text] [Related]
2. Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma. Broniscer A; Baker SJ; Stewart CF; Merchant TE; Laningham FH; Schaiquevich P; Kocak M; Morris EB; Endersby R; Ellison DW; Gajjar A Clin Cancer Res; 2009 Jan; 15(2):701-7. PubMed ID: 19147777 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study. Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972 [TBL] [Abstract][Full Text] [Related]
5. Use of an In-line Digestive Cartridge With Enteral Nutrition Improves the Weight Trajectory of 2 Children With Cystic Fibrosis Complicated by Another Medical Diagnosis. Giguere-Rich C; Mathew A; Reid E; Autore K; Guill MF Nutr Clin Pract; 2018 Apr; 33(2):286-294. PubMed ID: 29658186 [TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. Graff GR; McNamara J; Royall J; Caras S; Forssmann K Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415 [TBL] [Abstract][Full Text] [Related]
9. EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency. Wooldridge JL; Heubi JE; Amaro-Galvez R; Boas SR; Blake KV; Nasr SZ; Chatfield B; McColley SA; Woo MS; Hardy KA; Kravitz RM; Straforini C; Anelli M; Lee C J Cyst Fibros; 2009 Dec; 8(6):405-17. PubMed ID: 19683970 [TBL] [Abstract][Full Text] [Related]
10. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study. Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712 [TBL] [Abstract][Full Text] [Related]
11. Long-term experience with ZENPEP in infants with exocrine pancreatic insufficiency associated with cystic fibrosis. Wooldridge JL; Schaeffer D; Jacobs D; Thieroff-Ekerdt R J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):612-5. PubMed ID: 25050848 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis. Littlewood JM; Wolfe SP; Conway SP Pediatr Pulmonol; 2006 Jan; 41(1):35-49. PubMed ID: 16288483 [TBL] [Abstract][Full Text] [Related]
13. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis. Kalnins D; Ellis L; Corey M; Pencharz PB; Stewart C; Tullis E; Durie PR J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):256-61. PubMed ID: 16540792 [TBL] [Abstract][Full Text] [Related]
14. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038 [TBL] [Abstract][Full Text] [Related]
15. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT. Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537 [TBL] [Abstract][Full Text] [Related]
16. Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis. Mischler EH; Parrell S; Farrell PM; Odell GB Am J Dis Child; 1982 Dec; 136(12):1060-3. PubMed ID: 7148760 [TBL] [Abstract][Full Text] [Related]